Medical News Today, Aug. 22, 2008 UTMB's Dr. Christine Turley is quoted in this article about a new influenza vaccine that has passed its first phase of testing. "We'd characterize this influenza vaccine candidate as very promising, based upon the immune responses and tolerability we saw in the clinical trial participants," Turley said.